Trial intelligence / Profile preview

Dexamethasone Dose Comparison in Malignant Spinal Cord Compression

NCT00193869Phase 2Completed

Sponsor
Trans-Tasman Radiation Oncology Group
Start
Sep 2001
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of dexamethasone in malignant spinal cord compression (MSCC), sponsored by Trans-Tasman Radiation Oncology Group. Started Sep 2001; status: completed.

02

Drugs

dexamethasone
03

Conditions

malignant spinal cord compression (MSCC)

Beyond the preview

Go deeper on NCT00193869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00193869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call